gip and glp-1 receptor agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity Overweight The Emerging Role of Dual

Historically, there was significant concern for notoriety bias (i.e., increased likelihood of case reporting when patients are exposed to a drug with a negative reputation), which was mitigated by studying disproportionality signals

Spielman LJ, Gibson DL, Klegeris A

Resistance training and adequate protein intake are the most effective strategies for minimizing metabolic adaptation

Clinical trials have demonstrated significant benefits of prescription GLP-1 agonists

These agonists/analogues of GLP-1 slow down gastric emptying, modulate calorie intake by increasing the sense of satiety, modulate cardiovascular activity, and regulate natriuresis at the renal level [6]

Y., Kim, Y